Attorneys at Hagens Berman Announce $474M Win in Amitiza Jury Trial Against Takeda

BOSTON--(BUSINESS WIRE)---- $TAK #antitrust--A class-action lawsuit regarding Amitiza ended today when a jury found Takeda Pharmaceuticals liable for $474 million, according to Hagens Berman.